Medical Design Technology -
2 Mar 2018 22:38
News Altering a powerful immune-signaling chemical plus its receptor on immune cells may bring a promising cancer treatment closer to the clinic, according to a study led by investigators at the Stanford University School of Medicine. If the advance proves as beneficial in humans as in ... Contributed Author: Stanford University Topics: Oncology
Share this Article